The ACR is greatly saddened by the loss of Lori Gilbert-Kaye, wife of rheumatologist Howard Kaye, MD. Mrs. Gilbert-Kaye was tragically killed in the San Diego-area synagogue shooting on April 27 after she dove in front of Rabbi Yisroel Goldstein, saving his life. We send our deepest condolences to Dr. Kaye and his family. CNN… [Read More]
Editor Keri Losavio has been a professional editor and writer in the medical and financial fields for 20 years and joined the Wiley team in February 2014. She has written for and edited newsletters, magazines, personal memoirs, book proposals, dissertations, textbooks and more.
Articles by Keri Losavio
Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD
“It is with a profoundly heavy heart that I share with you the sad news that we have lost one of our most beloved leaders at NIH. Steve Katz, MD, PhD, the long-time director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), died early this morning after suffering a catastrophic stroke…. [Read More]
Study Finds Chronic Fatigue Clues in Overactive Immune Response
LONDON (Reuters)—Scientists exploring what may trigger chronic fatigue syndrome (CFS) have found clues in the way some people’s immune systems respond to interferon alpha.1 The researchers used the drug to create a model of the disease in people without CFS but with hepatitis C. Many patients who receive interferon alpha experience extreme fatigue during treatment,… [Read More]
ARHP Lifetime Achievement Award Winner: Christina H. Opava, PhD, RPT
CHICAGO—Christina H. Opava, PhD, RPT, is the recipient of the 2018 ARHP Lifetime Achievement Award, which was presented (along with the other ACR and ARHP awards) during the opening session of the 2018 ACR/ARHP Annual Meeting on Oct. 20. “Receiving this award is an immense honor,” she tells The Rheumatologist. “My first thought was that… [Read More]
Heart of a Champion: The 2018 ACR/ARHP Annual Meeting Kicks Off with Dramatic Keynote
“You’re probably going to die tonight. You should call your family.” Jonathan Koch, president and CCO of Asylum Entertainment LLC, told his touching and inspiring story of mysterious illness, resilience and recovery in the keynote presentation of the 2018 ACR/ARHP Annual Meeting.... [Read More]
Down Time at the 2018 ACR/ARHP Annual Meeting: What to See & Do in Chicago
With the 2018 ACR/ARHP Annual Meeting nearly upon us, the time has come to plan your trip to Chicago. The Annual Meeting is Oct. 19–24 at McCormick Center, which means attendees will see beautiful views of Lake Michigan and the Chicago skyline, highlighting the city’s unique architecture. The weather in October, although unpredictable, is generally… [Read More]
The ACR Updates Biosimilar Position Statement
In March, the ACR released a white paper designed primarily to help rheumatologists and rheumatology health professionals gain an understanding of biosimilars.1 This research-based education piece examines the scientific, economic and prescribing issues related to the use of biosimilars. Now, the ACR has released an update to its official position statement on the use of… [Read More]
Back to the Future: Spotlight on ACR Past President Dr. Herbert Kaplan
We are sad to report that Dr. Kaplan passed away on Saturday, June 23. We are reposting this story now to celebrate his life.... [Read More]
From AIDS to Zika: ‘What’s next?’ asked Dr. Anthony Fauci in keynote address at the 2017 ACR/ARHP Annual Meeting
SAN DIEGO—The 2017 ACR/ARHP Annual Meeting kicked off on Nov. 4 with a rousing presentation by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID). A terrorist attack on U.S. soil, hurricane, cyberattack and pandemic were the four scenarios played out in late 2016, when NIAID conducted a tabletop… [Read More]
Opinion: Help Bring Drug Prices Down
I read with interest the articles in the June issue of The Rheumatologist pertaining to high drug costs. Simon Helfgott rheuminated on it, and Susan Bernstein, a medical journalist, wrote a two-page article titled “Concerns About Cost.” Both articles were thoughtful summaries of a complex issue, putting large question marks over both initial prices and… [Read More]